| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Arrest | 5 | 2018 | 277 | 1.770 |
Why?
|
| Anesthesiologists | 2 | 2018 | 30 | 1.180 |
Why?
|
| Cardiopulmonary Resuscitation | 3 | 2018 | 222 | 0.910 |
Why?
|
| Intraoperative Complications | 3 | 2015 | 185 | 0.910 |
Why?
|
| Operating Rooms | 3 | 2018 | 125 | 0.830 |
Why?
|
| Anesthesia | 4 | 2016 | 166 | 0.790 |
Why?
|
| Data Interpretation, Statistical | 2 | 2019 | 302 | 0.710 |
Why?
|
| Intensive Care Units | 6 | 2020 | 397 | 0.570 |
Why?
|
| Data Mining | 1 | 2016 | 43 | 0.540 |
Why?
|
| Sample Size | 1 | 2016 | 125 | 0.530 |
Why?
|
| Physician's Role | 1 | 2018 | 176 | 0.530 |
Why?
|
| Databases, Factual | 2 | 2016 | 860 | 0.510 |
Why?
|
| Disease Management | 1 | 2018 | 326 | 0.510 |
Why?
|
| Biomedical Research | 1 | 2019 | 402 | 0.480 |
Why?
|
| Clinical Alarms | 3 | 2019 | 16 | 0.460 |
Why?
|
| Molecular Imaging | 1 | 2015 | 65 | 0.460 |
Why?
|
| Limb Deformities, Congenital | 1 | 2012 | 20 | 0.420 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2012 | 13 | 0.400 |
Why?
|
| Informed Consent | 1 | 2015 | 275 | 0.400 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2015 | 185 | 0.400 |
Why?
|
| Mammography | 1 | 2015 | 474 | 0.380 |
Why?
|
| General Practice | 1 | 2011 | 9 | 0.380 |
Why?
|
| Correspondence as Topic | 1 | 2011 | 4 | 0.380 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1132 | 0.380 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 419 | 0.360 |
Why?
|
| Femoracetabular Impingement | 2 | 2020 | 11 | 0.340 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 365 | 0.330 |
Why?
|
| Postoperative Complications | 3 | 2015 | 2297 | 0.300 |
Why?
|
| Drosophila Proteins | 4 | 2022 | 510 | 0.300 |
Why?
|
| Referral and Consultation | 1 | 2011 | 344 | 0.300 |
Why?
|
| Safety Management | 2 | 2011 | 56 | 0.300 |
Why?
|
| Mental Fatigue | 2 | 2018 | 9 | 0.300 |
Why?
|
| Humans | 44 | 2020 | 89688 | 0.290 |
Why?
|
| Organizational Culture | 1 | 2007 | 35 | 0.290 |
Why?
|
| Anesthesia, General | 3 | 2011 | 116 | 0.280 |
Why?
|
| Hospital Units | 1 | 2007 | 30 | 0.280 |
Why?
|
| Nursing Staff, Hospital | 1 | 2007 | 42 | 0.280 |
Why?
|
| Critical Illness | 6 | 2018 | 307 | 0.250 |
Why?
|
| Drosophila melanogaster | 2 | 2022 | 614 | 0.240 |
Why?
|
| Blood Glucose | 1 | 2009 | 837 | 0.240 |
Why?
|
| Consciousness Monitors | 2 | 2015 | 3 | 0.230 |
Why?
|
| Pulmonary Alveoli | 2 | 2015 | 71 | 0.220 |
Why?
|
| Monitoring, Intraoperative | 2 | 2015 | 109 | 0.210 |
Why?
|
| Wings, Animal | 2 | 2022 | 98 | 0.210 |
Why?
|
| Larva | 3 | 2022 | 122 | 0.200 |
Why?
|
| Water-Electrolyte Balance | 1 | 2001 | 67 | 0.190 |
Why?
|
| Emergency Medical Services | 2 | 2015 | 242 | 0.190 |
Why?
|
| Lactic Acid | 1 | 2001 | 92 | 0.190 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 100 | 0.190 |
Why?
|
| Chlorides | 1 | 2001 | 104 | 0.190 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 3022 | 0.180 |
Why?
|
| Awareness | 1 | 2001 | 88 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 1180 | 0.180 |
Why?
|
| Blood Gas Analysis | 1 | 2020 | 38 | 0.170 |
Why?
|
| Body Patterning | 1 | 2022 | 216 | 0.170 |
Why?
|
| Respiration, Artificial | 4 | 2010 | 351 | 0.170 |
Why?
|
| Catheters | 1 | 2020 | 83 | 0.170 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2020 | 101 | 0.160 |
Why?
|
| Uncertainty | 1 | 2019 | 76 | 0.160 |
Why?
|
| Osteoarthritis, Hip | 1 | 2018 | 22 | 0.160 |
Why?
|
| Propofol | 4 | 2001 | 92 | 0.150 |
Why?
|
| Perioperative Period | 1 | 2018 | 25 | 0.150 |
Why?
|
| Oxygen | 2 | 2020 | 744 | 0.150 |
Why?
|
| Electroencephalography | 2 | 2011 | 756 | 0.150 |
Why?
|
| Hemocytes | 1 | 2017 | 4 | 0.150 |
Why?
|
| Inhibin-beta Subunits | 1 | 2017 | 4 | 0.150 |
Why?
|
| Hematopoietic System | 1 | 2017 | 13 | 0.150 |
Why?
|
| Resuscitation | 1 | 2018 | 110 | 0.150 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2022 | 663 | 0.140 |
Why?
|
| Sensory Receptor Cells | 1 | 2017 | 37 | 0.140 |
Why?
|
| Critical Care | 2 | 2019 | 384 | 0.140 |
Why?
|
| Data Accuracy | 1 | 2016 | 32 | 0.140 |
Why?
|
| Inventions | 1 | 2016 | 13 | 0.140 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2017 | 102 | 0.140 |
Why?
|
| Machine Learning | 1 | 2019 | 263 | 0.140 |
Why?
|
| Hematopoiesis | 1 | 2017 | 168 | 0.130 |
Why?
|
| Probability | 1 | 2016 | 350 | 0.130 |
Why?
|
| Middle Aged | 12 | 2015 | 26046 | 0.130 |
Why?
|
| Research Design | 1 | 2019 | 589 | 0.130 |
Why?
|
| Hypotension | 1 | 2015 | 71 | 0.120 |
Why?
|
| Biomarkers | 4 | 2018 | 1769 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2016 | 273 | 0.120 |
Why?
|
| Airway Management | 1 | 2015 | 46 | 0.120 |
Why?
|
| Heart Diseases | 1 | 2016 | 298 | 0.110 |
Why?
|
| Checklist | 1 | 2014 | 61 | 0.110 |
Why?
|
| Radiation Dosage | 1 | 2015 | 226 | 0.110 |
Why?
|
| Risk Factors | 3 | 2015 | 5524 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 6775 | 0.110 |
Why?
|
| Prospective Studies | 6 | 2015 | 4315 | 0.110 |
Why?
|
| Midazolam | 3 | 2000 | 48 | 0.110 |
Why?
|
| Drosophila | 3 | 2008 | 522 | 0.110 |
Why?
|
| Female | 16 | 2018 | 46445 | 0.110 |
Why?
|
| Naltrexone | 3 | 2000 | 137 | 0.110 |
Why?
|
| Aged | 8 | 2015 | 19190 | 0.110 |
Why?
|
| Narcotic Antagonists | 3 | 2000 | 161 | 0.110 |
Why?
|
| Models, Statistical | 1 | 2016 | 575 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2015 | 161 | 0.110 |
Why?
|
| Adult | 11 | 2018 | 26735 | 0.110 |
Why?
|
| Perioperative Care | 1 | 2014 | 168 | 0.100 |
Why?
|
| Anesthesiology | 1 | 2015 | 157 | 0.100 |
Why?
|
| Hypnotics and Sedatives | 3 | 2000 | 132 | 0.100 |
Why?
|
| Male | 18 | 2018 | 42528 | 0.100 |
Why?
|
| Cystatin C | 2 | 2010 | 27 | 0.100 |
Why?
|
| Esophagus | 1 | 2012 | 107 | 0.100 |
Why?
|
| Anal Canal | 1 | 2012 | 88 | 0.100 |
Why?
|
| Intraoperative Awareness | 1 | 2011 | 2 | 0.100 |
Why?
|
| Spine | 1 | 2012 | 102 | 0.100 |
Why?
|
| Accreditation | 1 | 2011 | 61 | 0.090 |
Why?
|
| Trachea | 1 | 2012 | 291 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2015 | 1498 | 0.090 |
Why?
|
| Hypocapnia | 1 | 2010 | 6 | 0.090 |
Why?
|
| Fever of Unknown Origin | 1 | 2010 | 4 | 0.090 |
Why?
|
| Anesthetics, Inhalation | 1 | 2011 | 97 | 0.090 |
Why?
|
| Absorptiometry, Photon | 1 | 2011 | 102 | 0.090 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2011 | 96 | 0.090 |
Why?
|
| Time Factors | 6 | 2012 | 5338 | 0.090 |
Why?
|
| Radiography | 1 | 2012 | 806 | 0.090 |
Why?
|
| Electroconvulsive Therapy | 1 | 2010 | 25 | 0.090 |
Why?
|
| Registries | 1 | 2015 | 792 | 0.090 |
Why?
|
| Cardiopulmonary Bypass | 3 | 2000 | 158 | 0.090 |
Why?
|
| Age Factors | 1 | 2015 | 1879 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2014 | 1101 | 0.090 |
Why?
|
| Osteoporosis | 1 | 2011 | 124 | 0.080 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2009 | 47 | 0.080 |
Why?
|
| False Positive Reactions | 2 | 2020 | 223 | 0.080 |
Why?
|
| Cytomegalovirus Infections | 1 | 2010 | 149 | 0.080 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2009 | 94 | 0.080 |
Why?
|
| Abdominal Pain | 1 | 2010 | 142 | 0.080 |
Why?
|
| Arthroscopy | 2 | 2020 | 93 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2014 | 792 | 0.080 |
Why?
|
| Kidney Function Tests | 1 | 2009 | 115 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2015 | 2489 | 0.080 |
Why?
|
| Monitoring, Physiologic | 2 | 2019 | 265 | 0.080 |
Why?
|
| Depressive Disorder, Major | 1 | 2010 | 166 | 0.080 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 168 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2008 | 3398 | 0.080 |
Why?
|
| Algorithms | 2 | 2018 | 1903 | 0.080 |
Why?
|
| Infant | 1 | 2015 | 3178 | 0.080 |
Why?
|
| Activins | 1 | 2007 | 26 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1607 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2015 | 3757 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2008 | 127 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2019 | 9141 | 0.070 |
Why?
|
| Vision, Ocular | 1 | 2007 | 71 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2008 | 479 | 0.070 |
Why?
|
| Hospital Administration | 1 | 2007 | 26 | 0.070 |
Why?
|
| United States | 3 | 2015 | 7061 | 0.070 |
Why?
|
| Kidney | 1 | 2012 | 1147 | 0.070 |
Why?
|
| Axons | 1 | 2007 | 181 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2020 | 8231 | 0.070 |
Why?
|
| Liver Failure, Acute | 1 | 2006 | 39 | 0.070 |
Why?
|
| Acute Kidney Injury | 1 | 2010 | 316 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 351 | 0.070 |
Why?
|
| Conscious Sedation | 2 | 1997 | 69 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2008 | 320 | 0.060 |
Why?
|
| Heart Failure | 1 | 2015 | 1196 | 0.060 |
Why?
|
| Brain | 2 | 2007 | 2301 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 2 | 2008 | 326 | 0.060 |
Why?
|
| Insulin | 1 | 2009 | 1148 | 0.060 |
Why?
|
| Gastrointestinal Transit | 2 | 2000 | 19 | 0.050 |
Why?
|
| Interleukin-8 | 2 | 2000 | 86 | 0.050 |
Why?
|
| Child | 1 | 2015 | 7220 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2000 | 127 | 0.050 |
Why?
|
| Prostatectomy | 1 | 2006 | 474 | 0.050 |
Why?
|
| Equipment Design | 2 | 2018 | 420 | 0.050 |
Why?
|
| Receptors, Steroid | 1 | 2003 | 42 | 0.050 |
Why?
|
| Young Adult | 1 | 2015 | 6377 | 0.050 |
Why?
|
| Morphine | 2 | 2000 | 130 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 2009 | 854 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2011 | 1062 | 0.050 |
Why?
|
| Adolescent | 1 | 2015 | 9315 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2003 | 319 | 0.050 |
Why?
|
| Triglycerides | 1 | 2001 | 233 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 194 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2001 | 153 | 0.040 |
Why?
|
| Pancreatic Elastase | 1 | 2000 | 15 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2000 | 223 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2000 | 57 | 0.040 |
Why?
|
| Drug Interactions | 2 | 2017 | 244 | 0.040 |
Why?
|
| Lipocalin-2 | 2 | 2010 | 37 | 0.040 |
Why?
|
| Methadone | 1 | 2000 | 46 | 0.040 |
Why?
|
| Lipocalins | 2 | 2010 | 35 | 0.040 |
Why?
|
| Acute-Phase Proteins | 2 | 2010 | 37 | 0.040 |
Why?
|
| Wakefulness | 2 | 1997 | 135 | 0.040 |
Why?
|
| Knowledge Bases | 1 | 2019 | 14 | 0.040 |
Why?
|
| Expert Systems | 1 | 2019 | 18 | 0.040 |
Why?
|
| Constipation | 1 | 2000 | 64 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2000 | 206 | 0.040 |
Why?
|
| Cartilage Oligomeric Matrix Protein | 1 | 2018 | 2 | 0.040 |
Why?
|
| Positive-Pressure Respiration | 1 | 1999 | 40 | 0.040 |
Why?
|
| Pain | 1 | 2001 | 399 | 0.040 |
Why?
|
| Neutrophils | 1 | 2000 | 311 | 0.040 |
Why?
|
| Analgesics, Opioid | 2 | 2000 | 451 | 0.040 |
Why?
|
| Athletes | 1 | 2018 | 52 | 0.040 |
Why?
|
| Hip Joint | 1 | 2018 | 54 | 0.040 |
Why?
|
| Sleep Hygiene | 1 | 2018 | 3 | 0.040 |
Why?
|
| Physical Examination | 1 | 1999 | 149 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2014 | 2764 | 0.040 |
Why?
|
| Cholinergic Agonists | 1 | 2017 | 11 | 0.040 |
Why?
|
| Carbachol | 1 | 2017 | 36 | 0.040 |
Why?
|
| Animals | 6 | 2022 | 27494 | 0.040 |
Why?
|
| Peripheral Nervous System | 1 | 2017 | 21 | 0.040 |
Why?
|
| Pattern Recognition, Automated | 1 | 2019 | 219 | 0.040 |
Why?
|
| Discrimination Learning | 1 | 2018 | 63 | 0.040 |
Why?
|
| Drug Hypersensitivity | 1 | 2017 | 37 | 0.040 |
Why?
|
| Music | 1 | 2018 | 31 | 0.040 |
Why?
|
| Cellular Microenvironment | 1 | 2017 | 29 | 0.040 |
Why?
|
| Proteins | 1 | 2003 | 786 | 0.040 |
Why?
|
| Oxygen Consumption | 2 | 1996 | 245 | 0.040 |
Why?
|
| Hepatopulmonary Syndrome | 1 | 2016 | 3 | 0.040 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2016 | 12 | 0.030 |
Why?
|
| Auditory Perception | 1 | 2018 | 97 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 1997 | 120 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2003 | 1532 | 0.030 |
Why?
|
| Cytokines | 1 | 2000 | 806 | 0.030 |
Why?
|
| Smad2 Protein | 2 | 2007 | 22 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2016 | 115 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2010 | 665 | 0.030 |
Why?
|
| Single-Blind Method | 2 | 2011 | 151 | 0.030 |
Why?
|
| Forecasting | 1 | 2016 | 304 | 0.030 |
Why?
|
| Endotoxins | 1 | 1995 | 36 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 983 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 3 | 2000 | 81 | 0.030 |
Why?
|
| American Heart Association | 1 | 2015 | 95 | 0.030 |
Why?
|
| Hypoxia | 2 | 2016 | 657 | 0.030 |
Why?
|
| Respiratory Mechanics | 1 | 2015 | 102 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2015 | 158 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 1798 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 1995 | 279 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2016 | 354 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 653 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 2001 | 1713 | 0.030 |
Why?
|
| Escherichia coli | 1 | 1995 | 607 | 0.020 |
Why?
|
| Thrombelastography | 1 | 1992 | 47 | 0.020 |
Why?
|
| Physician Assistants | 1 | 2011 | 21 | 0.020 |
Why?
|
| Nurse Practitioners | 1 | 2011 | 30 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 1992 | 116 | 0.020 |
Why?
|
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2010 | 17 | 0.020 |
Why?
|
| Lymphocytosis | 1 | 2010 | 12 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2010 | 75 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 2016 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2010 | 112 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 1051 | 0.020 |
Why?
|
| Masks | 1 | 2010 | 29 | 0.020 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2010 | 84 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2010 | 125 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2011 | 172 | 0.020 |
Why?
|
| Semiconductors | 1 | 2009 | 11 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 1995 | 805 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 336 | 0.020 |
Why?
|
| Israel | 1 | 2009 | 57 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2010 | 201 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 387 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2009 | 89 | 0.020 |
Why?
|
| Injections, Intravenous | 2 | 2001 | 238 | 0.020 |
Why?
|
| Interleukin-6 | 2 | 2000 | 260 | 0.020 |
Why?
|
| Telemedicine | 1 | 2011 | 191 | 0.020 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2008 | 21 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 431 | 0.020 |
Why?
|
| Disulfides | 1 | 2008 | 65 | 0.020 |
Why?
|
| Growth Cones | 1 | 2007 | 4 | 0.020 |
Why?
|
| alpha Karyopherins | 1 | 2007 | 10 | 0.020 |
Why?
|
| ROC Curve | 1 | 2010 | 776 | 0.020 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2007 | 21 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 384 | 0.020 |
Why?
|
| Seizures | 1 | 2010 | 308 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2007 | 32 | 0.020 |
Why?
|
| Presynaptic Terminals | 1 | 2007 | 41 | 0.020 |
Why?
|
| Physicians | 1 | 2015 | 691 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 313 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2008 | 196 | 0.020 |
Why?
|
| Elective Surgical Procedures | 1 | 2008 | 128 | 0.020 |
Why?
|
| Supine Position | 1 | 2006 | 30 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2007 | 195 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2009 | 453 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2000 | 699 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 740 | 0.020 |
Why?
|
| Mutation | 2 | 2008 | 4163 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2006 | 296 | 0.020 |
Why?
|
| Kinetics | 1 | 2008 | 1534 | 0.020 |
Why?
|
| Alleles | 1 | 2008 | 1139 | 0.010 |
Why?
|
| Computational Biology | 1 | 2008 | 551 | 0.010 |
Why?
|
| Ischemia | 1 | 2006 | 252 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 1855 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 1491 | 0.010 |
Why?
|
| Cell Movement | 1 | 2007 | 786 | 0.010 |
Why?
|
| Mushroom Bodies | 1 | 2003 | 3 | 0.010 |
Why?
|
| Activin Receptors, Type II | 1 | 2003 | 9 | 0.010 |
Why?
|
| Activin Receptors, Type I | 1 | 2003 | 13 | 0.010 |
Why?
|
| Quality of Life | 1 | 2011 | 1674 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 2003 | 53 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 3788 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 2884 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 276 | 0.010 |
Why?
|
| Emulsions | 1 | 2001 | 19 | 0.010 |
Why?
|
| Liver | 1 | 2006 | 1208 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 288 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2003 | 280 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1764 | 0.010 |
Why?
|
| Tablets, Enteric-Coated | 1 | 2000 | 6 | 0.010 |
Why?
|
| Breath Tests | 1 | 2000 | 57 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2003 | 443 | 0.010 |
Why?
|
| Lactulose | 1 | 2000 | 22 | 0.010 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2000 | 47 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2000 | 305 | 0.010 |
Why?
|
| Auscultation | 1 | 1999 | 5 | 0.010 |
Why?
|
| Palpation | 1 | 1999 | 18 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1999 | 270 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 865 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2000 | 666 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 1999 | 251 | 0.010 |
Why?
|
| Gastrointestinal Agents | 1 | 2000 | 173 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 885 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2000 | 870 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1997 | 64 | 0.010 |
Why?
|
| Actins | 1 | 2000 | 461 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 1244 | 0.010 |
Why?
|
| Length of Stay | 1 | 2000 | 744 | 0.010 |
Why?
|
| APACHE | 1 | 1996 | 22 | 0.010 |
Why?
|
| Patients' Rooms | 1 | 1996 | 14 | 0.010 |
Why?
|
| RNA | 1 | 2000 | 583 | 0.010 |
Why?
|
| Gene Expression | 1 | 2000 | 1309 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1996 | 416 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1995 | 45 | 0.010 |
Why?
|
| Vasodilation | 1 | 1995 | 93 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1995 | 84 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1995 | 177 | 0.010 |
Why?
|
| Arginine | 1 | 1995 | 138 | 0.010 |
Why?
|
| Observer Variation | 1 | 1996 | 614 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 1589 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1999 | 1728 | 0.010 |
Why?
|
| Dogs | 1 | 1995 | 705 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1995 | 996 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1995 | 899 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1996 | 497 | 0.010 |
Why?
|
| Hematocrit | 1 | 1992 | 68 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1992 | 63 | 0.010 |
Why?
|
| Blood Coagulation Tests | 1 | 1992 | 35 | 0.010 |
Why?
|
| Intestines | 1 | 1995 | 416 | 0.010 |
Why?
|
| Heart Valve Prosthesis | 1 | 1992 | 98 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1995 | 731 | 0.010 |
Why?
|
| Drainage | 1 | 1992 | 165 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 1928 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 1992 | 236 | 0.010 |
Why?
|